🇺🇸 Oncaspar in United States

FDA authorised Oncaspar on 1 February 1994

Marketing authorisations

FDA — authorised 1 February 1994

  • Application: BLA103411
  • Marketing authorisation holder: SIGMA TAU
  • Status: supplemented

FDA

  • Status: approved

Oncaspar in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Oncaspar approved in United States?

Yes. FDA authorised it on 1 February 1994; FDA has authorised it.

Who is the marketing authorisation holder for Oncaspar in United States?

SIGMA TAU holds the US marketing authorisation.